Lv1
42 积分 2024-10-19 加入
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial
3天前
已完结
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
4天前
已完结
The PESGA Trial: A prospective, open-label, single-arm, phase II study to evaluate first line therapy for extensive-stage small cell lung cancer (ES-SCLC) patients, treated by induction carboplatin/etoposide/pembrolizumab followed by maintenance of pembrolizumab/ sacituzumab govitecan
8天前
已完结
Redefining the Fight Against SCLC: Standards, Innovations, and New Horizons
9天前
已完结
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer
3个月前
已完结
Histone deacetylase 6 in cancer
3个月前
已完结
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
3个月前
已完结
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
3个月前
已完结
VEGF in Signaling and Disease: Beyond Discovery and Development
3个月前
已完结
Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy
3个月前
已完结
皖公网安备34019202002308
